Finland· FI-REL-REL9374
Naramig
A naratriptan product containing naratriptan hydrochloride, registered in Finland by GlaxoSmithKline Oy. The same ATC class is registered in 15 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Naratriptan is registered in 15 of 19 countries.
Countries holding a registration under ATC N02CC02 (naratriptan), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Naratriptan · ATC N02CC02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of naratriptan costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.25 in France to $6.45 in Switzerland — a ×5.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Naratriptan · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$6.45
- ES Spain$3.63
- FR France$1.25
The record
At a glance
Fimea (Finland)- Active substance
- Naratriptan hydrochloride
- Manufacturer
- GlaxoSmithKline Oy
- Country
- Finland (FI)
- ATC code
- N02CC02
- ATC class
- Naratriptan
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa4899636EUR 12.17
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
50 interactions on record for naratriptan.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naratriptan · interactions on record
50 records
- 11 severe
- 6 moderate
- 5 minor
- 27 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Naratriptan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNARAMIGGlaxoSmithKline Trading Services Limited, Dublin
- FranceNARAMIG 2,5 mg, comprimé pelliculéGLAXOSMITHKLINE
- SwedenNaramig 2,5 mg Filmdragerad tablettGlaxoSmithKline AB
- BelgiumNaramig 2.5 mgPI Pharma
- NetherlandsNaramig, filmomhulde tabletten 2,5 mgGlaxoSmithKline B.V.
- NorwayNaramig2care4 ApS
- United StatesNaratriptanBionpharma Inc.
- SpainNARAMIG 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAGlaxo S.A.
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Belgium · Naramig, Naratriptan Sandoz
- Bulgaria · Нарворан Мигрена
- Czechia · Naramig
- Germany · Formigran, Naradex
- Denmark · Naratriptan Teva, Naxtrin
- Spain · Naramig
- France · Naramig, Naratriptan Arrow
- United Kingdom (Northern Ireland) · Naramig, Naratriptan
- Ireland · Naratriptan 2.5 Mg Tablet, Naraverg
- Lithuania · Naramig, Naratriptan Inteli
- Luxembourg · Naramig
- Malta · Naratriptan Renata Pharmaceuticals (Ireland)
- Netherlands · Naramig, Naratriptan Cf
- Norway · Naratriptan Orifarm, Naxtrin
- Portugal · Naramig, Naratriptano Renata
- Romania · Nacralid, Naratriptan Stada Hemofarm
- Sweden · Naramig, Naratriptan Orifarm
- Slovenia · Naramig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/89f8e6f8-303f-4f9d-ad11-fa07d2be09ea GET /v1/drugs/89f8e6f8-303f-4f9d-ad11-fa07d2be09ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2.5",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "mg",
"strength": "2.5 mg",
"atc_label": "naratriptaani",
"ma_number": "12783",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL9374",
"authorised_at": "1997-08-11"
}See everything about naratriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.